Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 2 1Phase 1/2 1

Status

Completed 6

Sponsor Class

NIH 6OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Thoracic 2Sarcoma 1Plasma cell 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 54Specimen Handling 48aldesleukin 35Docetaxel 30Biopsy 28Bevacizumab 24Gemcitabine 21Cyclophosphamide 21Cisplatin 21Radiotherapy 19Prednisone 17Sorafenib 16Carboplatin 16sargramostim 15PROSTVAC 15Paclitaxel 14Interferon-alpha 14Sunitinib 13ixabepilone 12cabozantinib 12Immunoglobulin G 12Goserelin 12Disulfides 12fludarabine phosphate 11fludarabine 11Nivolumab 11Fluorouracil 11Chemotherapy, Adjuvant 11pembrolizumab 10bicalutamide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
NIH × Suramin × Genitourinary × Clear all
NCT00083109 2015-05-25

Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer

National Cancer Institute (NCI)

Phase 1/2 Completed
36 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00006476 2013-06-26

Suramin in Treating Patients With Recurrent Bladder Cancer

National Cancer Institute (NCI)

Phase 1 Completed
15 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00002723 2013-02-28

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Completed
390 enrolled
Genitourinary

Prostatic Neoplasms

NCT00002881 2010-11-09

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Genitourinary

Prostatic Neoplasms

NCT00001266 2008-03-04

A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
70 enrolled
Genitourinary

Prostatic Neoplasms

NCT00001381 2008-03-04

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
18 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡